Press Release

Download PDF (65.7 KB)

May 15, 2015

Announcement on Changes in Financial Forecast (May 15, 2015)

Reflecting recent business activities, the financial forecast for FY2015 announced on February 6, 2015 is revised as follows.

1.Revision of Consolidated Forecast FY2015

For fiscal year ending June 30, 2015 (July 1, 2014 - June 30, 2015)

(Unit: Million yen, %)

2. The reason for changes in Financial Forecast FY2015

As stated in the Summary of Consolidated Financial Statement for the first 9 months of the fiscal year ending June 30, 2015 announced today (May 15, 2015), commission revenue was obtained from Elitech Group for the OEM supply agreement. The bottom line is maintained profitable for the 3rd quarter (January-March 2015) of this first 9 months financial statement by the commission revenue, which was already taken into account in the previous financial forecast.

As to the fully automated DNA testing instrument "geneLEAD XII", the product is in the final phase of development, however, the development cost should be borne for another while till the completion. With this cost, the bottom line is expected to be negative profit again for the 4th quarter (April-June 2015) of this fiscal year.

In the annual forecast, the operating loss is expected to improve by 20 million yen and that is because R&D expense for the 3rd quarter (January-March 2015) is supposed to decrease in comparison to the one in the previous forecast.

In addition, a governmental subsidy of 77 million yen for the new plant in Akita prefecture (Odate Reagent Center) or R&D subsidy by NEDO was finalized to contribute to non-operating income and the forecast for ordinary loss and net loss has been revised accordingly.

*This financial forecast is prepared based on the information available as of the announcement date and the final result is subject to change due to various factors to arise from now on,.

(End)